Metraipolis › archive › dc_662be11a2fd0

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma — Europe PMC PMID:40855067

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40855067
DOI
10.1038/s41419-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-10T08:40:02.689Z
SHA-256 of the archived text
c81d84a17f0af03cb41be643c9400ba0db3ca62047f1179b7694454b721d705b
Stable URL of this page
https://metraipolis.com/documento/dc_662be11a2fd0

How to cite

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma — Europe PMC PMID:40855067 — Europe PMC (en), https://europepmc.org/article/MED/40855067 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_662be11a2fd0 (Metraipolis archive dc_662be11a2fd0, sha256 c81d84a17f0af03cb41be643c9400ba0db3ca62047f1179b7694454b721d705b)
BibTeX
@misc{dc662be11a2fd0,
  title = {Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma — Europe PMC PMID:40855067},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40855067},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_662be11a2fd0; sha256 c81d84a17f0af03cb41be643c9400ba0db3ca62047f1179b7694454b721d705b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40855067. Agents can read the archived copy with the MCP tool read_document.